Literature DB >> 18383876

The ATM gene and ataxia telangiectasia.

Ariadni Mavrou1, George Th Tsangaris, Eleftheria Roma, Aggeliki Kolialexi.   

Abstract

Ataxia telangiectasia (AT) is a rare neurodegenerative, autosomal recessive disorder characterized by chromosome instability, radiosensitivity, immunodeficiency and a predisposition for cancer. Epidemiological studies have shown that AT heterozygotes have a predisposition for cancer, especially for breast cancer in women. The disease is caused by mutations in the ATM gene, leading to total loss of the ATM protein, which normally recognizes DNA damage, activates the DNA repair machinery and the cell cycle check points in order to minimize the risk of genetic damage. This review summarizes the clinical features of AT and the natural history of the disease and puts recent molecular advances into the context of the cellular and clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383876

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  26 in total

Review 1.  The cerebellum, cerebellar disorders, and cerebellar research--two centuries of discoveries.

Authors:  Mario Manto
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

2.  Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises.

Authors:  Anita Villani; David Malkin; Uri Tabori
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

3.  Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia.

Authors:  Matan Kraus; Atar Lev; Amos J Simon; Inbal Levran; Andrea Nissenkorn; Yonit B Levi; Yackov Berkun; Ori Efrati; Ninette Amariglio; Gideon Rechavi; Raz Somech
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

Review 4.  Genetic determinants at the interface of cancer and neurodegenerative disease.

Authors:  L G T Morris; S Veeriah; T A Chan
Journal:  Oncogene       Date:  2010-04-26       Impact factor: 9.867

5.  Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression.

Authors:  Alejo Efeyan; Matilde Murga; Barbara Martinez-Pastor; Ana Ortega-Molina; Rebeca Soria; Manuel Collado; Oscar Fernandez-Capetillo; Manuel Serrano
Journal:  PLoS One       Date:  2009-05-07       Impact factor: 3.240

6.  UV but not X rays stimulate homologous recombination between sister chromatids and homologs in a Saccharomyces cerevisiae mec1 (ATR) hypomorphic mutant.

Authors:  Michael Fasullo; Mingzeng Sun
Journal:  Mutat Res       Date:  2008-09-25       Impact factor: 2.433

Review 7.  Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2013-12-04       Impact factor: 6.730

8.  Tau Mutations Serve as a Novel Risk Factor for Cancer.

Authors:  Giacomina Rossi; Veronica Redaelli; Paolo Contiero; Sabrina Fabiano; Giovanna Tagliabue; Paola Perego; Luisa Benussi; Amalia C Bruni; Graziella Filippini; Mariangela Farinotti; Giorgio Giaccone; Simona Buiatiotis; Claudia Manzoni; Raffaele Ferrari; Fabrizio Tagliavini
Journal:  Cancer Res       Date:  2018-05-24       Impact factor: 12.701

9.  Validation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer risk.

Authors:  Jeff W Hill; Kristina Tansavatdi; Kristin L Lockett; Glenn O Allen; Cristiane Takita; Alan Pollack; Jennifer J Hu
Journal:  Cancer Manag Res       Date:  2009-04-30       Impact factor: 3.989

Review 10.  Inflammation, a significant player of Ataxia-Telangiectasia pathogenesis?

Authors:  Majid Zaki-Dizaji; Seyed Mohammad Akrami; Gholamreza Azizi; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  Inflamm Res       Date:  2018-03-26       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.